Indranil Banerjee

Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy

Indranil Banerjee, Kakali De, Dibyanti Mukherjee et al. · Acta Biomaterialia · 2016 · 94 citations

Nanoparticles, Nanomedicine, Engineering +9

Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy

Rashmi Bharti, Goutam Dey, Indranil Banerjee et al. · Cancer Letters · 2016 · 79 citations

Breast Oncology, Immunology, Breast Cancer Therapy +7

A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes

Manjarika De, Sneha Ghosh, Triparna Sen et al. · Molecular Therapy — Nucleic Acids · 2017 · 58 citations · Full text

Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma

Y. Rajesh, Angana Biswas, Utkarsh Kumar et al. · Biochemical Pharmacology · 2019 · 54 citations

Neuro-oncology, Transcription Factor Upstream, Temozolomide Resistant Glioblastoma +8

A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model

Indranil Banerjee, Manjarika De, Goutam Dey et al. · Biomaterials Science · 2019 · 48 citations